OUTASERVICE
My zealous pioneer sib says everything goes smoothly for me cuz the "world loves its own" (edit- pfffff!!!...maybe me in an alternate reality..)
LEO
I'm glad that made ya smile. Being close to the Great Lakes, my avian nemesis is the seagull. I got hit twice by those buggers at the most embarrassing of times. Once in my mid teens, at a nice conservation area (Christie's near Hamilton), with my cousin and a mix of his cool and hot friends witnessing it. Another time in my mid twenties, at Canada's WonderLand (a theme-park north of Toronto) with some JWs - that wouldn't let up on it for the rest of the day.
I really hope the arrhythmia turns out to be a temporary sitch, or at least nothing serious. Do you like eating fish? Here's an abstract you might find interesting:
omega3 fatty acids in the prevention-management of cardiovascular disease
Simopoulos A.P.
A.P. Simopoulos, Center Genetics, Nutrition and Hlth, 2001 S Street N.W., Washington, DC 20009 USA
Canadian Journal of Physiology and Pharmacology (Canada), 1997, 75/3 (234-239)
Epidemiologic studies show that populations who eat fish versus those who do not have a reduced death rate from cardiovascular disease. Experimental studies have shown that omega-3 fatty acids affect the function of cells involved in atherothrombosis in numerous ways, including the modification of eicosanoid products in the cyclooxygenase and lipoxygenase pathways, the reduced synthesis of cytokines and platelet-derived growth factor, and alterations of leukocyte and endothelial cell properties. Intervention studies in patients with restenosis, myocardial infarction, and cardiac arrhythmias with omega-3 fatty acid supplementation have been addressed in several clinical studies. The ingestion of omega-3 fatty acids following one episode of myocardial infarction appears to decrease the rate of cardiac death. These effects of omega-3 fatty acids appear to be due to their antiarrhythmic properties. In fact, fish oil has been shown to reduce ventricular arrhythmias and to be more beneficial than currently used pharmacologic agents. The dose, duration, and mechanisms involved in the prevention and management of cardiovascular disease following omega-3 fatty acid ingestion or supplementation need to be investigated by double blind controlled clinical trials.